Polysialylated NCAM is highly expressed in many types of cancers, including neuroblastoma, lung cancer, breast cancer, and pancreatic cancer, and its presence is associated with late stage, poorly differentiated, and highly invasive and metastatic disease (2, 23). This evidence concerns the gene NCAM1 and metastatic neoplasm.